Feedback / Questions
imifoplatin (PT-112) - Promontory Therap
https://www.prnewswire.com/news-releases/promontory-therapeutics-announces-successful-end-of-phase-2-meeting-with-us-fda-on-phase-3-registrational-study-design-for-pt-112-in-patients-with-metastatic-castration-resistant-prostate-cancer-302459819.html
May 20, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next